Forudsigelse af gastrisk cancer i intestinal metaplasi og atrofisk gastritis (GIMA)
Forudsigelse af gastrisk kræft i intestinal metaplasi og atrofisk gastritis - Anvendelse af kunstig intelligens i histologi og kliniske data
The primary objectives of this study are:
- To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG
- To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
Studieoversigt
Status
Status
Betingelser
Betingelser
Detaljeret beskrivelse
This is a two-part retrospective study including a clinical data part and a pathology part. A training cohort will be developed from approximately 70% of included cases. It will be followed by a validation cohort with the remaining cases.
Clinical data will be collected retrospectively using the Clinical Data Analysis and Reporting System (CDARS) and Clinical management System (CMS). A cluster-wide cohort (New Territories East Cluster, NTEC) consisting of patients with history of histologically-proven gastric IM and AG will be identified and included for subsequent analysis. The data collection period for the retrospective data will be 2000-2020.
Histology slides will be retrieved retrospectively when available (within NTEC). Whole slide imaging technique will be utilized for the development of training and validation cohorts with machine learning algorithms in the pathology part.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Felix Sia
- Telefonnummer: +85226370428
- E-mail: felix.sia@cuhk.edu.hk
Undersøgelse Kontakt Backup
- Navn: Thomas Lam
- Telefonnummer: +85226370428
- E-mail: thomas.lam@cuhk.edu.hk
Studiesteder
-
-
New Territories
-
Shatin, New Territories, Hong Kong
- Rekruttering
- Prince of Wales Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Clinical data will be collected retrospectively using the Clinical Data Analysis and Reporting System (CDARS) and Clinical management System (CMS). A cluster-wide cohort (New Territories East Cluster, NTEC) consisting of patients with history of histologically-proven gastric IM and AG will be identified and included for subsequent analysis. The data collection period for the retrospective data will be 2000-2020.
Histology slides will be retrieved retrospectively when available (within NTEC). Whole slide imaging technique will be utilized for the development of training and validation cohorts with machine learning algorithms in the pathology part.
Beskrivelse
Inclusion Criteria:
- Adults >= 18 years of age
- Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)
Exclusion Criteria:
- none
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: RETROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
|---|
|
Intestinal Metaplasia
patient with history of histologically proven gastric intestinal metaplasia |
|
Atrophic gastritis
patient with history of histologically proven atrophic gastritis |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Gastric cancer and gastric dysplasia
Tidsramme: 20 years
|
The primary endpoint is the incidence of gastric cancer (intestinal-type) and gastric dysplasia (low grade and high grade dysplasia). |
20 years
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall accuracy of machine learning model
Tidsramme: 20 years
|
Overall accuracy of machine learning models will be evaluated |
20 years
|
|
Sensitivity of machine learning model
Tidsramme: 20 years
|
Sensitivity of machine learning model will be evaluated |
20 years
|
|
Specificity of machine learning model
Tidsramme: 20 years
|
Specificity of machine learning model will be evaluated |
20 years
|
|
Positive predictive value of machine learning model
Tidsramme: 20 years
|
Positive predictive value of machine learning model will be evaluated |
20 years
|
|
Negative predictive value of machine learning model
Tidsramme: 20 years
|
Negative predictive value of machine learning model will be evaluated |
20 years
|
|
Area under the receiver operating characteristic curve of machine learning model
Tidsramme: 20 years
|
Area under the receiver operating characteristic curve of machine learning model will be evaluated |
20 years
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2021.082
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
There is no plan to share IPD with other researchers
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .